Maiko Yoshikawa

773 total citations
15 papers, 550 citations indexed

About

Maiko Yoshikawa is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Maiko Yoshikawa has authored 15 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Rheumatology and 4 papers in Epidemiology. Recurrent topics in Maiko Yoshikawa's work include T-cell and B-cell Immunology (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Maiko Yoshikawa is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Maiko Yoshikawa collaborates with scholars based in Japan, China and Belgium. Maiko Yoshikawa's co-authors include Shingo Nakayamada, Satoshi Kubo, Yoshiya Tanaka, Yusuke Miyazaki, S. Iwata, Kazuhisa Nakano, Kazuyoshi Saito, Ippei Miyagawa, Yoshiya Tanaka and Kei Sakata and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Maiko Yoshikawa

14 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maiko Yoshikawa Japan 11 342 340 78 69 68 15 550
Yoshie Sanayama Japan 10 171 0.5× 332 1.0× 95 1.2× 39 0.6× 62 0.9× 17 582
Lucian Ionescu United Kingdom 7 299 0.9× 308 0.9× 158 2.0× 32 0.5× 29 0.4× 9 599
Valérie Badot Belgium 12 142 0.4× 221 0.7× 57 0.7× 73 1.1× 39 0.6× 26 413
Mauro Waldemar Keiserman Brazil 13 452 1.3× 549 1.6× 241 3.1× 109 1.6× 75 1.1× 31 736
A M Delgado-Vega Sweden 12 273 0.8× 278 0.8× 35 0.4× 64 0.9× 60 0.9× 20 485
GR Burmester Germany 10 248 0.7× 310 0.9× 49 0.6× 66 1.0× 54 0.8× 28 495
Ida E.M. Coremans Netherlands 10 250 0.7× 297 0.9× 32 0.4× 105 1.5× 22 0.3× 17 551
Kouichi Amano Japan 15 216 0.6× 575 1.7× 165 2.1× 96 1.4× 77 1.1× 35 758
Panagiotis Garantziotis Greece 11 217 0.6× 237 0.7× 46 0.6× 67 1.0× 48 0.7× 26 402
Lucas L. van den Hoogen Netherlands 14 254 0.7× 209 0.6× 62 0.8× 25 0.4× 26 0.4× 21 536

Countries citing papers authored by Maiko Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Maiko Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maiko Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maiko Yoshikawa more than expected).

Fields of papers citing papers by Maiko Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maiko Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maiko Yoshikawa. The network helps show where Maiko Yoshikawa may publish in the future.

Co-authorship network of co-authors of Maiko Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Maiko Yoshikawa. A scholar is included among the top collaborators of Maiko Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maiko Yoshikawa. Maiko Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Nishimura, Tomoyasu, Maiko Yoshikawa, Yuki Enoki, et al.. (2025). Combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro. Journal of Global Antimicrobial Resistance. 42. 142–150.
2.
Miyazaki, Yusuke, Shingo Nakayamada, Satoshi Kubo, et al.. (2020). Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation. Arthritis Research & Therapy. 22(1). 141–141. 12 indexed citations
3.
Kubo, Satoshi, Shingo Nakayamada, Yusuke Miyazaki, et al.. (2019). Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis. Lara D. Veeken. 58(12). 2273–2283. 25 indexed citations
4.
Mori, Hiroko, Yosuke Okada, S. Iwata, et al.. (2019). A Study of the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis. Internal Medicine. 58(10). 1383–1390. 8 indexed citations
5.
Ma, Xiaoxue, Shingo Nakayamada, Satoshi Kubo, et al.. (2018). Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors. Annals of the Rheumatic Diseases. 77(9). 1354–1361. 67 indexed citations
6.
Yoshikawa, Maiko, Shingo Nakayamada, Satoshi Kubo, et al.. (2018). Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus. Clinical Immunology. 200. 1–9. 10 indexed citations
7.
Miyagawa, Ippei, Shingo Nakayamada, Kazuhisa Nakano, et al.. (2018). Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis. Lara D. Veeken. 58(2). 336–344. 78 indexed citations
8.
Tanaka, Yoshiya, et al.. (2017). B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus. Clinical Immunology. 186. 21–25. 35 indexed citations
9.
Nakayamada, Shingo, Satoshi Kubo, Maiko Yoshikawa, et al.. (2017). Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis. Lara D. Veeken. 57(1). 164–174. 71 indexed citations
10.
Kubo, Satoshi, Shingo Nakayamada, Maiko Yoshikawa, et al.. (2017). Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease. Lara D. Veeken. 57(3). 514–524. 57 indexed citations
11.
Kubo, Satoshi, Shingo Nakayamada, Maiko Yoshikawa, et al.. (2017). Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients. Arthritis & Rheumatology. 69(10). 2029–2037. 88 indexed citations
12.
Kurozumi, Akira, Yosuke Okada, Tadashi Arao, et al.. (2016). Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report. Endocrinology Diabetes and Metabolism Case Reports. 2016. 160020–160020. 8 indexed citations
13.
Iwata, S., Shingo Nakayamada, Hiroaki Niiro, et al.. (2015). Amplification of IL-21 signalling pathway through Bruton’s tyrosine kinase in human B cell activation. Lara D. Veeken. 54(8). 1488–1497. 36 indexed citations
14.
Yoshikawa, Maiko, et al.. (2015). Abnormal expression of chemokine receptor on B cells in patients with SLE. Japanese Journal of Clinical Immunology. 38(1). 65–68. 1 indexed citations
15.
Iwata, S., Shingo Nakayamada, Shunsuke Fukuyo, et al.. (2014). Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept Therapy. Arthritis & Rheumatology. 67(1). 63–73. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshie Sanayama Breakdown of academic impact, for papers by Lucian Ionescu Breakdown of academic impact, for papers by Valérie Badot Breakdown of academic impact, for papers by Mauro Waldemar Keiserman Breakdown of academic impact, for papers by A M Delgado-Vega Breakdown of academic impact, for papers by GR Burmester Breakdown of academic impact, for papers by Ida E.M. Coremans Breakdown of academic impact, for papers by Kouichi Amano Breakdown of academic impact, for papers by Panagiotis Garantziotis Breakdown of academic impact, for papers by Lucas L. van den Hoogen
Rankless by CCL
2026